ASHLEIGH BARS: Open Payments
NPI 1356759948 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 22 payments from 8 companies in 2025. Trend: 2023 $415 · 2024 $546 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $191 |
| PFIZER INC. | 4 | $67 |
| Stryker Corporation | 1 | $45 |
| ITF Therapeutics LLC | 1 | $33 |
| Averitas Pharma Inc. | 1 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Boston Scientific Corporation | 1 | $19 |
Products named: BOTOX, NURTEC ODT, UBRELVY, LIMFLOW SYSTEM, QUTENZA, Dysport, RELISTOR, Intracept.
Industry payments across ID — which companies pay providers there.
